Announcement PDF Application for quotation of +securities Announcement Summary Entity name BPH GLOBAL LTD Announcement Type New announcement Date of this announcement Friday December 08, 2023 The +securities to be quoted are: Other Total number of +securities to be quoted ASX +security code Security description BP8 ORDINARY FULLY PAID Refer to next page for full details of the announcement Application for quotation of +securities 1/8 Number of +securities to be quoted Issue date 100,000,000 08/12/2023 Application for quotation of +securities Part 1 - Entity and announcement details 1.1 Name of entity BPH GLOBAL LTD We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type Registration number ACN 009104330 1.3 ASX issuer code BP8 1.4 The announcement is New announcement 1.5 Date of this announcement 8/12/2023 Application for quotation of +securities 2/8 Application for quotation of +securities Part 2 - Type of Issue 2.1 The +securities to be quoted are: Other 2.2 The +securities to be quoted are: Additional +securities in a class that is already quoted on ASX ("existing class") 2.3c Have these +securities been offered under a +disclosure document or +PDS? No 2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B Issue of shares approved by shareholders at the AGM held on 21 November 2023. Refer to resolution 13 in the Notice of Meeting https://announcements.asx.com.au/asxpdf/20231020/pdf/05w9rbpw3zzth0.pdf 2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: Not applicable - the entity has arrangements in place with the holder that ensure the securities cannot be on-sold within 12 months in a manner that would breach section 707(3) or 1012C(6) Application for quotation of +securities 3/8 Application for quotation of +securities Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B Additional +securities to be quoted in an existing class ASX +security code and description BP8 : ORDINARY FULLY PAID Issue date 8/12/2023 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 100,000,000 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities Issued for nil consideration Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.005000 Any other information the entity wishes to provide about the +securities to be quoted As part of the consideration for Foshan Gedishi Biotechnology Co Ltd. The purpose(s) for which the entity is issuing the securities Other Please provide additional details Issue of shares approved by shareholders at the AGM held on 21 November 2023. Refer to resolution 13 in the Notice of Meeting https://announcements.asx.com.au/asxpdf/20231020/pdf/05w9rbpw3zzth0.pdf Application for quotation of +securities 4/8 Application for quotation of +securities Application for quotation of +securities 5/8 Application for quotation of +securities Part 4 - Issued capital following quotation Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise: (A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.) 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application) Total number of +securities on issue ASX +security code and description BP8 : ORDINARY FULLY PAID 1,715,563,114 BP8O : OPTION EXPIRING 07-JUL-2027 220,834,319 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) Total number of +securities on issue ASX +security code and description BP8AU : OPTION EXPIRING 01-SEP-2025 EX $0.018 27,666,664 BP8AB : CONVERTIBLE NOTES 368,750 BP8AI : OPTION EXPIRING 09-APR-2026 EX $0.017 25,000,000 BP8AJ : OPTION EXPIRING 01-NOV-2027 EX $0.05 25,000,000 BP8AA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 10,600,000 BP8AL : OPTION EXPIRING 23-APR-2024 EX $0.04 110,000,000 BP8AM : OPTION EXPIRING 28-FEB-2027 EX $0.017 5,000,000 BP8AN : OPTION EXPIRING 28-FEB-2027 EX $0.02 5,000,000 BP8AO : OPTION EXPIRING 28-FEB-2027 EX $0.01 500,000 BP8AP : OPTION EXPIRING 28-FEB-2025 EX $0.025 15,000,000 BP8AQ : OPTION EXPIRING 28-FEB-2025 EX $0.05 7,500,000 BP8AR : OPTION EXPIRING 28-FEB-2025 EX $0.075 2,500,000 Application for quotation of +securities 6/8 Application for quotation of +securities Application for quotation of +securities 7/8 Application for quotation of +securities Part 5 - Other Listing Rule requirements 5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No 5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? Yes 5.2a Date of meeting or proposed meeting to approve the issue under listing rule 7.1 21/11/2023 Application for quotation of +securities 8/8